Identification of HLA-DRB1 association to adalimumab immunogenicity - Liu, Mohan; Degner, Jacob; Davis, Justin Wade; Idler, Kenneth B.; Nader, Ahmed; Mostafa, Nael M.; Waring, Jeffrey F. (PloS one, 2018)
Keywords: Adalimumab; Adalimumab - immunology; Adalimumab - therapeutic use; Alleles; Analysis; Anti-Inflammatory Agents - immunology; Anti-Inflammatory Agents - therapeutic use; Antibodies; Antigens; Antirheumatic Agents - immunology; Antirheumatic Agents - therapeutic use; Arthritis; Arthritis, Rheumatoid - blood; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - genetics; Arthritis, Rheumatoid - immunology; Autoantibodies; Biology and Life Sciences; Clinical trials; Dosage and administration; Drb1 protein; Drug dosages; Drug therapy; Genomics; Health aspects; Hidradenitis Suppurativa - blood; Hidradenitis Suppurativa - drug therapy; Hidradenitis Suppurativa - genetics; Hidradenitis Suppurativa - immunology; Histocompatibility antigen HLA; Histocompatibility Testing; HLA antigens; HLA-DQ beta-Chains - blood; HLA-DQ beta-Chains - genetics; HLA-DRB1 Chains - genetics; Humans; Immunogenicity; Immunoglobulins; Immunotherapy; Infliximab; Interferon; Medical research; Medicine and Health Sciences; Monoclonal antibodies; Multiple sclerosis; Patients; Pharmacogenomic Variants; Philosophy of science; Physiological aspects; Research and Analysis Methods; Rheumatoid arthritis; Sequence Analysis; Skin diseases; Tissue typing; TNF inhibitors; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Values; United States--US; North Chicago Illinois